These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20686833)

  • 61. The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
    Jones S; Stokoe C; Sborov M; Braun M; Ethirajan S; Kutteh L; Pippen J; Patel M; Paul D; Blum JL; Holmes FA; Myron MC; Cantrell J; Hartung NL; Look RM; Di Salle E; Davis JC; Ilegbodu D; Asmar L
    Clin Breast Cancer; 2008 Dec; 8(6):527-32. PubMed ID: 19073509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
    Böttcher J; Pfeil A; Lehmann G; Heinrich B; Malich A; Hansch A; Petrovitch A; Mentzel HJ; Hein G; Kaiser WA
    Z Rheumatol; 2004 Dec; 63(6):473-82. PubMed ID: 15605213
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients.
    Müller C; Winter CC; Rosenbaum D; Boos J; Gosheger G; Hardes J; Vieth V
    BMC Musculoskelet Disord; 2010 Dec; 11():287. PubMed ID: 21190557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
    Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables.
    Meaney AM; O'Keane V
    Schizophr Res; 2007 Jul; 93(1-3):136-43. PubMed ID: 17467954
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.
    Love RR; Young GS; Laudico AV; Van Dinh N; Uy GB; Quang le H; De La Peña AS; Dofitas RB; Bisquera OC; Siguan SS; Salvador JD; Mirasol-Lumague MR; Navarro NS; Linh ND; Jarjoura D
    Cancer; 2013 Nov; 119(21):3746-52. PubMed ID: 23963821
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
    [TBL] [Abstract][Full Text] [Related]  

  • 69. FSH Levels Predict Bone Loss in Premenopausal Women Treated for Breast Cancer More Than One Year After Treatment.
    Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1257-62. PubMed ID: 26756114
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
    Park SY; Kang MI; Park HM; Rhee Y; Moon SH; Yoon HK; Koh JM; Chang JS; Kim IJ; Won YY; Park YS; Choi H; Shin CS; Yoon TR; Yun SC; Chung HY;
    Arch Osteoporos; 2019 Dec; 15(1):3. PubMed ID: 31820121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Are menopausal symptoms associated with bone mineral density and changes in bone mineral density in premenopausal women?
    Salamone LM; Gregg E; Wolf RL; Epstein RS; Black D; Palermo L; Kuller LH; Cauley JA
    Maturitas; 1998 Jun; 29(2):179-87. PubMed ID: 9651908
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density.
    Pal L; Norian J; Zeitlian G; Bevilacqua K; Freeman R; Santoro N
    Fertil Steril; 2008 Nov; 90(5):1626-34. PubMed ID: 18068159
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC).
    Urruticoechea A; Arnedos M; Walsh G; Dowsett M; Smith IE
    Breast Cancer Res Treat; 2008 Aug; 110(3):411-6. PubMed ID: 17851753
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
    Halper-Stromberg E; Gallo T; Champakanath A; Taki I; Rewers M; Snell-Bergeon J; Frohnert BI; Shah VN
    J Clin Endocrinol Metab; 2020 Mar; 105(3):746-53. PubMed ID: 31676897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer.
    Kalder M; Hans D; Kyvernitakis I; Lamy O; Bauer M; Hadji P
    J Clin Densitom; 2014; 17(1):66-71. PubMed ID: 23562130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.
    Malisic E; Susnjar S; Milovanovic J; Todorovic-Rakovic N; Kesic V
    Arch Gynecol Obstet; 2018 Feb; 297(2):495-503. PubMed ID: 29101609
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
    Massai R; Mäkäräinen L; Kuukankorpi A; Klipping C; Duijkers I; Dieben T
    Hum Reprod; 2005 Oct; 20(10):2764-8. PubMed ID: 15980008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
    Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
    Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study.
    Rosendahl M; Ahlgren J; Andersen J; Bergh J; Blomquist C; Lidbrink E; Lindman H; Mouridsen H; Bjerre K; Andersson M
    Eur J Cancer; 2009 Dec; 45(18):3198-204. PubMed ID: 19818599
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.
    Grey AB; Cundy TF; Reid IR
    Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.